Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
160 participants
OBSERVATIONAL
2015-09-30
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Characteristics of Patients With Nonsurgical Complications After Bariatric Surgery and Quality of Life
NCT05957237
NUTritional Impact of a Hypocaloric Hyperprotein Diet Before Obesity Surgery
NCT04942093
Protein Supplementation Post Bariatric Surgery
NCT02951663
Study of Bariatric Surgery
NCT02857179
Intraoperative Findings and Complications in Bariatric Surgery
NCT03556306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* albumin
* hemoglobin
* vitamin D (25-hydroxy vitamin D)
* ferritin
* folic acid
* vitamin B12
Standard treatment in this study will consist of the pre-operative work-up as advised by the guideline. Participants will have a consultation with the dietician to assess (protein) intake. In addition the first blood sample, which is part of standard treatment according to the new protocol, will be obtained to assess foregoing parameters. If there are nutritional deficiencies they will be treated according to the protocol of the department of Bariatric Surgery of the treating hospital.
To evaluate the effect of the treatment of deficiencies and to be sure that there are no deficiencies present during the BCS a second blood sample will be drawn during the body contouring procedure. For study purposes this second sample will be collected in all patients, even if a deficiency was not present at the first blood sample.
The dietician will assess current intake of the patients, with special attention the protein intake. Based on guidelines on protein-intake in post-bariatric patients and after consultation of experts (Dieticians of Maastricht University) investigators decided that the aim of the minimum protein intake is 1.5 gram per kilogram bodyweight (calculated with BMI 27kg/m2) per day. The first consultation at the dietician will be eight weeks prior to surgery. Patients will be advised to start with the extra protein-intake four weeks prior to surgery and continue this until the wounds are completely healed.
Six weeks after surgery a questionnaire will be handed-out to the patients, to assess the compliance to the treatment regime.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Body Contouring Surgery
All patients who undergo BCS after bariatric surgery.
protein intake assessment and optimisation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protein intake assessment and optimisation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing BCS because of skin surplus
* contouring in one of the following regions: abdomen, mammae, legs, arms, upper body or lower body.
Exclusion Criteria
* weight unstable in last 12 months
* diabetes mellitus defined by currently using either oral medication or insulin
* active smoker
* using immunosuppressive drugs, e.g. corticosteroids, methotrexate
* using anti-coagulants other than acetylsalicylic acid
* coagulopathy, vasculitis, connective tissue disorder
* kidney failure (GFR\<30) or liver failure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catharina Ziekenhuis Eindhoven
OTHER
St. Antonius Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valerie Monpellier
MD PhD candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aebele Mink van der Molen, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
Sint Antonius Hospital
Maarten Hoogbergen, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
Catharina Ziekenhuis Eindhoven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catharina Hospital
Eindhoven, North Brabant, Netherlands
Sint Antonius Hospital
Nieuwegein, Utrecht, Netherlands
Rijnstate Hospital
Arnhem, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R15.035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.